Taipei, Taiwan, 1 December 2022 -- Lotus Pharmaceuticals (1795:TT), a multinational pharmaceutical company, today announced it received the APEA Awards 2022 - "Corporate Excellence Award." And this is the second time Lotus to be awarded the Awards.
The prestigious Asia Pacific Enterprise Awards (APEA) is a Regional Award Recognition program recognizing entrepreneurial excellence. APEA honors business leaders and organizations that have shown outstanding performance and tenacity in developing successful businesses while not neglecting the social responsibilities that come with leadership.
Petar Vazharov, Chief Executive Officer of Lotus said: "This award is a recognition for seeing and affirming Lotus' continuous progress and efforts in recent years. In the third quarter of this year, Lotus has broken through the performance of previous quarters. Not only has it set a record in financials, but it has also set an important milestone in successfully delivering the largest product launch in the Company’s history in the US. The achievement of deliverables depends on the continuous efforts made by the management team and employees, who have also fulfilled their commitments to shareholders and patients through successful operation and strategy. Lotus' vision is "to become a global leader in developing and manufacturing oral oncology products and a preferred partner in the world." and aims to provide patients with affordable and high-quality drugs. We will continue to keep up the good work and move towards this goal."